Special - Hot Topic Themed Presentations
Sunday, October 13, 2024
12:45 PM–02:15 PM
Abstract
Service or Program: Establishing a pharmacotherapy clinic embedded in an academic health-system faculty medical group.
Justification/Documentation: Leadership at Loma Linda University school of pharmacy (LLUSP) and faculty medical group (FMG) approved a collaborative practice agreement (CPA) for a selected group of LLUSP faculty members to initiate a billable pharmacotherapy service at a standalone clinic. Serving faculty are residency trained, board certified, and credentialed. The team sought to provide chronic condition management through referrals from cardiology, endocrinology, family medicine, adult general medicine, and preventive medicine clinics. The purpose of this service is to enhance patient access to healthcare professional and timely adjustments in medications to prevent disease or medication related complications and improve medication therapy efficacy.
Adaptability: The inclusion criteria for referrals are adult patients with hemoglobin A1C of equal or greater than 8% and or systolic blood pressure of equal or greater than 130 mmHg and or diastolic blood pressure of equal or greater than 90 mmHg and or patients diagnosed with heart failure and difficult to controlled symptoms. Referred patients will be seen by the pharmacist at the clinic for an initial visit. Follow up visits are at 2 weeks for 2 visits and then monthly for another 2 visits either in-person or through tele-health. The goal for clinical outcomes is to bring the above-mentioned measures to the normal ranges. Patients will be discharged from pharmacotherapy clinic as the measures get stable within normal ranges and their condition is controlled.
Significance: This innovative pharmacotherapy service creates a new venue of pharmacist-based patient centered care under an approved CPA and establishes preventive care services to several vulnerable patient populations. The pharmacist services will be reimbursed by an insurance entity that covers Loma Linda University employees and their beneficiaries. The billing has been defined and approved based on the type and length of the visits.
Presenting Author
Jody Gonzalez PharmDLoma Linda University
Authors
Khaled Bahjri MD, MPH
Loma Linda University
Alireza Hayatshahi PharmD
Loma Linda University School of Pharmacy